Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

Murray Miranda I.; Markowitz Martin; Frank Ian; Grant Robert M.; Mayer Kenneth H.; Hudson Krischan J.; Stancil Britt S.; Ford Susan L.; Patel Parul; Rinehart Alex R.; Spreen William R.; Margolis David A.

首页> 外文期刊>HIV clinical trials >Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

【24h】

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

机译：Cabotegravir长效可注射悬浮液预防艾滋病毒症的满意和可接受性：eClair试验中的患者观点

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Cabotegravir (GSK1265744) is an integrase strand transfer inhibitor in development as a longacting (LA) intramuscular injectable suspension for HIV-1 pre-exposure prophylaxis (PrEP).

机译：背景：Cabotegravir（GSK1265744）是一种整合酶链转移抑制剂，其作为HIV-1预曝光预防（PREP）的致纲（LA）肌肉注射悬浮液（制备）。

著录项

来源
《HIV clinical trials》 |2018年第6期|共10页
作者
Murray Miranda I.; Markowitz Martin; Frank Ian; Grant Robert M.; Mayer Kenneth H.; Hudson Krischan J.; Stancil Britt S.; Ford Susan L.; Patel Parul; Rinehart Alex R.; Spreen William R.; Margolis David A.;
展开▼
作者单位

ViiV Healthcare London England;

Rockefeller Univ Aaron Diamond AIDS Res Ctr 1230 York Ave New York NY 10021 USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

Gladstone Inst Inst Virol &

Immunol San Francisco CA USA;

Fenway Hlth Fenway Inst Boston MA USA;

ViiV Healthcare Res Triangle Pk NC USA;

PAREXEL Int Durham NC USA;

GlaxoSmithKline Res Triangle Pk NC USA;

ViiV Healthcare Res Triangle Pk NC USA;

ViiV Healthcare Res Triangle Pk NC USA;

ViiV Healthcare Res Triangle Pk NC USA;

ViiV Healthcare Res Triangle Pk NC USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
Satisfaction; injectable; patient-reported outcomes; cabotegravir; pre-exposure prophylaxis;

机译：满意;注射;患者报告的结果;Cabotegravir;预曝光预防;

相似文献

外文文献
中文文献
专利

1. Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial [J] . Murray Miranda I., Markowitz Martin, Frank Ian, HIV clinical trials . 2018,第1a6期

机译：Cabotegravir长效可注射悬浮液预防艾滋病毒症的满意和可接受性：eClair试验中的患者观点
2. Long-acting injectable cabotegravir for the prevention of HIV infection [J] . Clement Meredith E., Kofron Ryan, Landovitz Raphael J. Current opinion in HIV and AIDS . 2020,第1期

机译：长效可注射的Cabotegravir用于预防艾滋病毒感染
3. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial [J] . Raphael J. Landovitz, Sue Li, Beatriz Grinsztejn, PLoS Medicine . 2018,第11期

机译：低风险未感染HIV的长效可注射卡博可韦的安全性，耐受性和药代动力学：HPTN 077，一项2a期随机对照试验
4. Preliminary Results from a Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Young Men [C] . Rebecca Schnall, Lisa Kuhns, Cynthia Pearson, Medical Informatics Europe Conference . 2020

机译：MyPeeps Mobile的务实临床试验中的初步结果改善了年轻人的艾滋病毒预防行为
5. Male Circumcision as a Bio-medical HIV Intervention Targeting Male Heterosexual Sexually Transmitted Disease (STD) Patients in China - An Acceptability Study and a Single-arm Test-of-concept Trial. [D] . Wang, Zixin. 2013

机译：男性包皮环切术作为针对中国男性异性恋性传播疾病（STD）患者的生物医学HIV干预-可接受性研究和单臂概念测试试验。
6. Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States [O] . D. Kerrigan, A. Mantsios, R. Grant, -1

机译：扩大艾滋病毒预防选择的范围：在美国进行第二阶段试验的背景下对长效可注射的卡博可韦作为PrEP的经验进行定性研究
7. Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial [O] . Miranda I. Murray, Martin Markowitz, Ian Frank, 2018

机译：Cabotegravir长效可注射悬浮液预防艾滋病毒症的满意和可接受性：eClah试验中的患者观点

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

摘要

著录项

相似文献

相关主题

期刊订阅